Optimizing bone health in chronic kidney disease

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Phosphocalcic metabolism disorders are common in chronic kidney disease (CKD), worsening with declining kidney function and impacting bone integrity.
• Patients with pre-dialysis CKD and end-stage renal disease (ESRD) face a significantly higher risk of fracture compared to the general population.
• Renal bone disorders represent a major global public health issue due to increasing CKD incidence, high fracture-related mortality, reduced quality of life, and economic burden.

Purpose of the Study:

• To review current understanding of mineral and bone disorders in CKD and ESRD patients.
• To evaluate the utility of existing and emerging techniques for assessing bone health in this population.
• To discuss preventive and therapeutic strategies for managing CKD-mineral and bone disorders (CKD-MBD).

Main Methods:

• Review of existing literature on CKD-MBD, bone health assessment, and management strategies.
• Analysis of the limitations of current diagnostic tools like Dual-energy X-ray absorptiometry (DXA) in advanced CKD.
• Exploration of novel non-invasive, high-resolution imaging techniques for bone strength assessment.

Main Results:

• Traditional methods like DXA are inadequate for assessing fracture risk in advanced CKD.
• Newer 3D high-resolution imaging techniques show promise in evaluating bone strength and improving fracture prediction.
• Early therapeutic intervention is vital to maintain mineral metabolism, prevent parathyroid hyperplasia and calcifications, and preserve skeletal health.

Conclusions:

• Optimizing bone health in CKD patients is a critical public health priority.
• Advanced imaging techniques may offer superior assessment of bone health compared to current methods in CKD.
• Proactive and early management of CKD-MBD is essential for preventing severe skeletal and extra-skeletal complications.